What Gynopolis does

Gynopolis is an India-based pharmaceutical company operating as a specialized women's healthcare division of Micropolis Lifesciences Private Limited, headquartered in Panchkula, Haryana. The company develops, manufactures, and distributes a portfolio of 60+ branded gynaecology products across eight therapeutic categories, including fertility and PCOS management, oral contraceptives, progesterone therapies, lactation support, menstrual health, and UTI/vaginal care. Manufacturing is conducted in WHO-GMP certified in-house facilities, and the product line spans tablets, capsules, sachets, syrups, injections, and topical formulations developed by an internal R&D team.

The company monetizes its portfolio through a PCD (Propaganda cum Distribution) pharma franchise model, granting territorial monopoly rights to franchise partners across India who purchase, market, and distribute products to gynaecologists, obstetricians, hospitals, clinics, and pharmacies. It supplements this primary distribution channel with a third-party manufacturing service for external brand owners and engages healthcare professionals directly via field sampling, visual aids, and healthcare events. End consumers reached through this network are women across all life stages, with the company claiming 5,000+ customers and 175,000+ couples supported through fertility formulations.

Name

Gynopolis

Legal name

Gynopolis

Website

https://gynopolis.in

Company type

Private

Operating status

Operating

Short description

Gynopolis is an India-based pharmaceutical division of Micropolis Lifesciences that manufactures and distributes 60+ branded gynaecology products through a PAN-India PCD pharma franchise network, serving franchise partners, gynaecologists, and women across all life stages.

Ownership category

akta.pro rank

Product category

Women's Health Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK), Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders) (HLAKAJAJ)

Keywords

• Women's health pharmaceuticals
• Gynecological formulations
• Gynae PCD franchise
• Fertility and PCOS medicines
• PCD pharma manufacturing India

Headquarters

HQ city

Panchkula

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

1. PCD Pharma Franchise Product Sales: Revenue is generated through the sale of gynecological pharmaceutical products via their PCD (Propaganda cum Distribution) franchise network. Franchise holders purchase products from the company and distribute them in their designated territories. The company offers monopoly rights to franchise partners and provides marketing collateral and support.
2. Third Party Manufacturing: The company offers third-party manufacturing services for gynecological products, allowing other companies to manufacture products under their brand or配方.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Gynopolis manufactures and distributes a complete range of women's health pharmaceutical formulations spanning fertility care, PCOS management, contraception, menstrual health, lactation support, UTI and vaginal care, and supplementation. The company sells its branded products primarily through a PCD (Propaganda cum Distribution) pharma franchise model, granting franchise holders monopoly distribution rights in designated Indian territories, and additionally offers third-party manufacturing services for gynecological products.

Product overview

Gynopolis is a specialized pharmaceutical company focused exclusively on women's healthcare, operating as a division of Micropolis Lifesciences Private Limited. The company offers a comprehensive portfolio of over 60 gynecological and reproductive health products across 8 major categories including Gynaecology, Lactation Related Products, Menstrual Problem Related Products, Oral Contraceptives, PCOS Management & Female Infertility, Progesterone Range, Supplementation & Nutrition, and UTI & Vaginal Care Products. The product portfolio includes branded formulations such as ALKATWIST, ARGIDAILY, ARGIDAILY PLUS, Carelacto, Clinpolis, CLINPOLIS-TZ, CLOMIPOLIS, Cranpolis, CYSTOKEY, OVAPOLIS, MYDIOL, PREGHOLD series, MENOPOLIS, FOLICOSA, CALDUB, DORNIK-PLUS, GYNOPOLIS-DHA, and contraceptive products like THREEWEEKS and NEXTSTEP-21DAYS. These products address conditions across all stages of a woman's life including early womanhood (menstrual care, UTI treatment), contraception phase, family planning (PCOS, infertility, progesterone-based therapies), and motherhood (lactation support). Gynopolis operates primarily through a PCD (Propaganda cum Distribution) pharma franchise model, providing business opportunities for distributors and entrepreneurs to market these products with monopoly rights in specific territories.

Differentiator

Problem solved

Functional benefit

Brands

• WinVision: Vision care division mentioned in navigation as part of Micropolis group.
• Winfertility

Products and services

• ALKATWIST™ UTI and vaginal care product formulated for treating urinary tract infections in women.
• ARGIDAILY® L-Arginine 3gm and Proanthocyanidin 75mg granules sachet for PCOS management and female infertility support.
• ARGIDAILY™ PLUS L-Arginine 3gm with Cyanocobalamine, Vitamin B12, Folic Acid, and DHA granules in orange flavour for female fertility support.
• Carelacto™ Capsule formulation for lactation support containing Shatavri, Ashwagandha, Yastimadhu, Methi, and Lasuna extracts.
• Carelacto™ Lactation Powder Powder formulation for supporting healthy lactation and milk supply in nursing mothers.
• Clinpolis Pharmaceutical product for UTI and vaginal care treatment.
• CLINPOLIS™ – TZ Combination antibiotic product for treating complex UTI and vaginal infections.
• CLOMIPOLIS™ M 100 Clomiphene Citrate 100mg with Melatonin 3mg for ovulation induction and PCOS management.
• Cranpolis® Syrup Cranberry-based suspension for UTI prevention and urinary tract health support.
• CRANPOLIS™ Cranberry-based formulation for urinary tract infection care and vaginal health.
• CYSTOKEY™ Myo-Inositol 1000mg with L-Methylfolate and Vitamin D3 tablets for PCOS management and metabolic support.
• CYSTOKEY™ – MET B/L Myo-Inositol combination with Metformin for enhanced PCOS and metabolic syndrome management.
• OVAPOLIS-2.5 Letrozole 2.5mg tablet for ovulation induction and fertility treatment.
• MYDIOL-35 Cyproterone acetate 2mg and Ethinyl estradiol 0.035mg tablet for hormonal balance and acne management in PCOS.
• PREGHOLD Depot 250 Hydroxyprogesterone Caproate 250mg injection for pregnancy support and prevention of preterm birth.
• PREGHOLD-MP Medroxyprogesterone Acetate 10mg tablet for hormonal support and menstrual regulation.
• PREGHOLD 300 SR Micronized Progesterone 300mg sustained release tablet for luteal phase support and fertility treatment.
• MENOPOLIS Soya Isoflavones, Calcitriol, Calcium, Vitamin K and Magnesium combination for menopause symptom management.
• ESTRAPOLIS Estradiol Valerate 2mg tablet for hormone replacement therapy.
• TEXAPOLIS-ET Tranexamic acid 250mg and Etamsylate 250mg combination for menstrual bleeding management.
• PRIMOTWIST 500 Evening Primrose 500mg supplement for women's health and hormonal balance.
• TEXAPOLIS-MF Tranexamic acid 500mg and Mefenamic acid 250mg tablet for heavy menstrual bleeding relief.
• PREGHOLD-200 SR Natural Micronized Progesterone 200mg sustained release tablet for fertility support and hormone balance.
• FOLICOSA Folic acid 5mg and DHA 200mg supplement for prenatal care and fetal development support.
• CALDUB Coral Calcium tablet providing Calcium 225mg and Vitamin D3 500IU for bone health support.
• DORNIK-PLUS Drotaverine 80mg and Mefenamic acid 250mg tablet for menstrual pain and dysmenorrhea relief.
• PRIMOTWIST 1000 Evening Primrose 1000mg supplement for women's health and hormonal support.
• GYNOPOLIS-DHA L-methylfolate, Mecobalamine, Pyridoxal 5 phosphate, DHA and Vitamin D3 combination for prenatal nutrition.
• THREEWEEKS Desogestrel 0.15mg and Ethinyl Estradiol 0.02mg oral contraceptive pill.
• NEXTSTEP-21DAYS Levonorgestrel 0.15mg and Ethinyl Estradiol 0.03mg oral contraceptive for family planning.
• DYDROZING™ Dydrogesterone 10mg tablet for progesterone support in fertility treatment and pregnancy maintenance.
• PCD Pharma Franchise Propaganda cum Distribution franchise opportunity allowing partners to market and distribute Gynopolis gynecological products in designated territories with monopoly rights, with marketing collateral and training support provided.
• Third-Party Manufacturing Service Contract manufacturing service for gynecological products, allowing other companies to have formulations manufactured under their own brand or composition using Gynopolis's WHO-GMP certified facilities.

Quantifiable outcome

• 1,75,000+ couples have overcome infertility using Gynopolis fertility formulations
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Micropolis Lifesciences Private LimitedcoreOthersGynopolis is a division of Micropolis Lifesciences Private Limited. As a subsidiary, Gynopolis operates under the parent company's WHO-GMP certifications and infrastructure for manufacturing and distributing gynecological pharmaceutical products.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Mankind Pharma: India's largest PCD-franchise-based pharma company with broad women's health and gynecological offerings. Comparable on the PCD distribution model and women's health category, though it operates across many other therapeutic areas.
• Sun Pharmaceutical Industries: India's largest pharma company with global scale, broad OB/GYN and hormonal franchises, and deep doctor relationships across India — a dominant incumbent competing for the same prescription volume in gynae.
• Zydus Cadila: Major Indian pharma with established women's health, hormonal, and supplement brands and a robust India distribution network. A broader incumbent that overlaps with Gynopolis on contraception, hormonal, and supplementation categories.
• Torrent Pharmaceuticals: Large Indian pharma with dedicated gynecology and women's healthcare marketing divisions. Competes for the same prescriber wallet in gynae therapies but is materially larger and more diversified across geographies.
• Cipla: India's largest pharma company by certain measures with presence in women's reproductive health, hormonal, and fertility categories. A broad incumbent whose gynae portfolio competes directly with Gynopolis in India's doctor channel.
• Lupin Limited: One of India's largest pharma companies with a meaningful women's health and hormonal portfolio and pan-India field force. Overlaps with Gynopolis in gynae and fertility but spans far wider therapy areas and global markets.

Direct peers

• Bharat Serums and Vaccines: India-based specialty pharma with a focused fertility, hormonal, and gynecological portfolio. Its premium niche positioning in reproductive health and its distribution in India overlap closely with Gynopolis's core franchise.
• Emcure Pharmaceuticals: Indian pharmaceutical company with a strong women's health, fertility, and hormonal therapy portfolio distributed across India via similar field and franchise models, making it a directly comparable gynae specialty peer.

Emerging players

• Theramex: Global women's health specialty company focused on contraception, fertility, menopause, and osteoporosis — a pure-play peer in women's health, though currently focused on Europe/International rather than India.
• Organon & Co. Women's health pure-play spun out of Merck with a portfolio in contraception, fertility, and hormone therapy. Closely comparable on therapeutic focus but operates globally rather than via India's PCD franchise model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gynopolis